NASDAQ: IOVAIovance Biotherapeutics Inc Earnings Dates, Reports, Calls
Iovance Biotherapeutics earnings were -$353.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest IOVA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$79.0M, up 9.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IOVA reported annual earnings of -$391.0M, with 5.1% growth.
IOVA earnings history
Current Revenue
$285.6M
Current Earnings
-$353.9M
Current Profit Margin
-123.9%
IOVA Return on Equity
Current Company
-50.2%
Current Industry
-142.1%
Current Market
14.1%
IOVA's Return on Equity (-50.2%)... subscribe to Premium to read more.
High Return on Equity Performance
IOVA Return on Assets
Current Company
-38.8%
Current Industry
-13.5%
IOVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when IOVA announces earnings.
IOVA Return on Capital Employed
Current Company
-44.55%
Current Industry
-9.4%
IOVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
IOVA vs Biotech Stocks
Iovance Biotherapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.